Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1976 Sep;19(3):833–845. doi: 10.1128/jvi.19.3.833-845.1976

Interactions of vesicular stomatitis virus with murine cell surface antigens.

T T Hecht, D F Summers
PMCID: PMC354924  PMID: 61285

Abstract

The process of maturation of vesicular stomatitis virus (VSV) results in the loss of 70% of the H-2k antigenic activity from L-cell plasma membranes. This phenomenon is also demonstrated during VSV infection of cells of the H-2d haplotype. Using the method of inhibition of immune cytolysis, VSV-infected L5178Y tissue culture cells and VSV-infected METH A fibrosarcoma cells grown in vivo show a loss of H-2d activity of 73 and 76%, respectively. Using monospecific antisera, it is seen that VSV infection results in a significant loss of antigenic activity of the gene products of both the H-2D and H-2K regions in cells of the H-2d and H-2k haplotypes. In hybrid cells expressing H-2k as well as H-2b, VSV infection results in the decrease of both H-2 antigenic activities to the same extent. VSV purified from L cells shows considerable H-2k activity, but the reaction of this virus with anti-H-2k serum does not prevent a normal subsequent infection with this virus. VSV may associate with H-2 antigen in the culture medium, but the results of mixing VSV with uninfected H-2-containing homogenates suggest that this association occurs only when the host cell and the cell homogenate share the same H-2 haplotype. Velocity sedimentation of VSV, which would remove contaminating cellular membrane fragments, does not separate H-2 activity from VSV. H-2 activity is also stably associated with VSV throughout sequential sucrose gradient centrifugation steps. It is possible that H-2 antigen is a structural component of VSV grown in murine cells.

Full text

PDF
833

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Takahashi T. Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med. 1972 Mar 1;135(3):443–457. doi: 10.1084/jem.135.3.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burge B. W., Huang A. S. Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol. 1970 Aug;6(2):176–182. doi: 10.1128/jvi.6.2.176-182.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burge B. W., Pfefferkorn E. R. Phenotypic mixing between group A arboviruses. Nature. 1966 Jun 25;210(5043):1397–1399. doi: 10.1038/2101397a0. [DOI] [PubMed] [Google Scholar]
  4. Burge B. W., Strauss J. H., Jr Glycopeptides of the membrane glycoprotein of Sindbis virus. J Mol Biol. 1970 Feb 14;47(3):449–466. doi: 10.1016/0022-2836(70)90314-1. [DOI] [PubMed] [Google Scholar]
  5. Choppin P. W., Compans R. W. Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol. 1970 May;5(5):609–616. doi: 10.1128/jvi.5.5.609-616.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cikes M., Friberg S., Jr, Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst. 1973 Feb;50(2):347–362. doi: 10.1093/jnci/50.2.347. [DOI] [PubMed] [Google Scholar]
  7. Cohen G. H., Atkinson P. H., Summers D. F. Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol. 1971 May 26;231(21):121–123. doi: 10.1038/newbio231121a0. [DOI] [PubMed] [Google Scholar]
  8. Cullen S. E., Nathenson S. G. Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments. J Immunol. 1971 Aug;107(2):563–570. [PubMed] [Google Scholar]
  9. Cullen S. E., Schwartz B. D., Nathenson S. G., Cherry M. The molecular basis of codominant expression of the histocompatibility-2 genetic region. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1394–1397. doi: 10.1073/pnas.69.6.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cullen S. E., Schwartz B. D., Nathenson S. G. The distribution of alloantigenic specificities of native H-2 products. J Immunol. 1972 Mar;108(3):596–600. [PubMed] [Google Scholar]
  11. Darlington G. J., Bernard H. P., Ruddle F. H. Human serum albumin phenotype activation in mouse hepatoma--human leukocyte cell hybrids. Science. 1974 Sep 6;185(4154):859–862. doi: 10.1126/science.185.4154.859. [DOI] [PubMed] [Google Scholar]
  12. FISCHER G. A. Studies of the culture of leukemic cells in vitro. Ann N Y Acad Sci. 1958 Dec 5;76(3):673–680. doi: 10.1111/j.1749-6632.1958.tb54884.x. [DOI] [PubMed] [Google Scholar]
  13. Gooding L. R., Edidin M. Cell surface antigens of a mouse testicular teratoma. Identification of an antigen physically associated with H-2 antigens on tumor cells. J Exp Med. 1974 Jul 1;140(1):61–78. doi: 10.1084/jem.140.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HOWATSON A. F., WHITMORE G. F. The development and structure of vesicular stomatitis virus. Virology. 1962 Apr;16:466–478. doi: 10.1016/0042-6822(62)90228-3. [DOI] [PubMed] [Google Scholar]
  15. Hecht T. T., Summers D. F. Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells. J Virol. 1972 Oct;10(4):578–585. doi: 10.1128/jvi.10.4.578-585.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hecht T. T., Summers D. F. Newcastle disease virus infection of L cells. J Virol. 1974 Jul;14(1):162–169. doi: 10.1128/jvi.14.1.162-169.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holland J. J., Kiehn E. D. Influenza virus effects on cell membrane proteins. Science. 1970 Jan 9;167(3915):202–205. doi: 10.1126/science.167.3915.202. [DOI] [PubMed] [Google Scholar]
  18. Huang A. S., Wagner R. R. Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A. 1965 Dec;54(6):1579–1584. doi: 10.1073/pnas.54.6.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jimenez L., Bloom B. R., Blume M. R., Oettgen H. F. On the number and nature of antigen-sensitive lymphocytes in the blood of delayed-hypersensitive human donors. J Exp Med. 1971 Apr 1;133(4):740–751. doi: 10.1084/jem.133.4.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kang C. Y., Prevec L. Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens. J Virol. 1969 Apr;3(4):404–413. doi: 10.1128/jvi.3.4.404-413.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klenk H. D., Choppin P. W. Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol. 1971 Mar;7(3):416–417. doi: 10.1128/jvi.7.3.416-417.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klenk H. D., Choppin P. W. Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A. 1970 May;66(1):57–64. doi: 10.1073/pnas.66.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Klenk H. D., Choppin P. W. Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology. 1969 Jun;38(2):255–268. doi: 10.1016/0042-6822(69)90367-5. [DOI] [PubMed] [Google Scholar]
  24. LITTLEFIELD J. W. SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS. Science. 1964 Aug 14;145(3633):709–710. doi: 10.1126/science.145.3633.709. [DOI] [PubMed] [Google Scholar]
  25. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  26. Littlefield J. W. The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exp Cell Res. 1966 Jan;41(1):190–196. doi: 10.1016/0014-4827(66)90558-1. [DOI] [PubMed] [Google Scholar]
  27. Maizel J. V., Jr Acrylamide-gel electrophorograms by mechanical fractionation: radioactive adenovirus proteins. Science. 1966 Feb 25;151(3713):988–990. doi: 10.1126/science.151.3713.988. [DOI] [PubMed] [Google Scholar]
  28. McSharry J. J., Compans R. W., Choppin P. W. Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol. 1971 Nov;8(5):722–729. doi: 10.1128/jvi.8.5.722-729.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McSharry J. J., Wagner R. R. Lipid composition of purified vesicular stomatitis viruses. J Virol. 1971 Jan;7(1):59–70. doi: 10.1128/jvi.7.1.59-70.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McSharry J., Benzinger R. Concentration and purification of vesicular stomatitis virus by polyethylene glycol "precipitation". Virology. 1970 Mar;40(3):745–746. doi: 10.1016/0042-6822(70)90219-9. [DOI] [PubMed] [Google Scholar]
  31. Mudd J. A., Summers D. F. Protein synthesis in vesicular stomatitis virus-infected HeLa cells. Virology. 1970 Oct;42(2):328–340. doi: 10.1016/0042-6822(70)90277-1. [DOI] [PubMed] [Google Scholar]
  32. Muramatsu T., Nathenson S. G. Studies on the carbohydrate portion of membrane-located mouse H-2 alloantigens. Biochemistry. 1970 Dec 8;9(25):4875–4883. doi: 10.1021/bi00827a008. [DOI] [PubMed] [Google Scholar]
  33. Nakai T., Howatson A. F. The fine structure of vesicular stomatitis virus. Virology. 1968 Jun;35(2):268–281. doi: 10.1016/0042-6822(68)90267-5. [DOI] [PubMed] [Google Scholar]
  34. Nathenson S. G. Biochemical properties of histocompatibility antigens. Annu Rev Genet. 1970;4(0):69–90. doi: 10.1146/annurev.ge.04.120170.000441. [DOI] [PubMed] [Google Scholar]
  35. Nathenson S. G., Davies D. A. Solubilization and partial purification of mouse histocompatibility antigens from a membranous lipoprotein fraction. Proc Natl Acad Sci U S A. 1966 Aug;56(2):476–483. doi: 10.1073/pnas.56.2.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Notkins A. L. Enzymatic and immunologic alterations in mice infected with lactic dehydrogenase virus. Am J Pathol. 1971 Sep;64(3):733–746. [PMC free article] [PubMed] [Google Scholar]
  37. PFEFFERKORN E. R., CLIFFORD R. L. THE ORIGIN OF THE PROTEIN OF SINDBIS VIRUS. Virology. 1964 Jun;23:217–223. doi: 10.1016/0042-6822(64)90285-5. [DOI] [PubMed] [Google Scholar]
  38. Ricciuti F. C., Ruddle F. H. Assignment of three gene loci (PGK, HGPRT, G6PD) to the long arm of the human X chromosome by somatic cell genetics. Genetics. 1973 Aug;74(4):661–678. doi: 10.1093/genetics/74.4.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schlesinger M. J. Formation of an infectious virus-antibody complex with Rous sarcoma virus and antibodies directed against the major virus glycoprotein. J Virol. 1976 Mar;17(3):1063–1067. doi: 10.1128/jvi.17.3.1063-1067.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schwartz B. D., Nathenson S. G. Regeneration of transplantation antigens on mouse cells. Transplant Proc. 1971 Mar;3(1):180–182. [PubMed] [Google Scholar]
  41. Shapiro A. L., Viñuela E., Maizel J. V., Jr Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun. 1967 Sep 7;28(5):815–820. doi: 10.1016/0006-291x(67)90391-9. [DOI] [PubMed] [Google Scholar]
  42. Shimada A., Nathenson S. G. Removal of neuraminic acid from H-2 alloantigens without effect of antigenic reactivity. J Immunol. 1971 Oct;107(4):1197–1199. [PubMed] [Google Scholar]
  43. Shimada A., Yamane K., Nathenson S. G. Comparison of the peptide composition of two histocompatibility-2 alloantigens. Proc Natl Acad Sci U S A. 1970 Mar;65(3):691–696. doi: 10.1073/pnas.65.3.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Snell G. D., Cherry M., Démant P. Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A. Transplant Proc. 1971 Mar;3(1):183–186. [PubMed] [Google Scholar]
  45. Ting C. C., Herberman R. B. Inverse relationship of polyoma tumour specific cell surface antigen to H-2 histocompatibility antigens. Nat New Biol. 1971 Jul 28;232(30):118–120. doi: 10.1038/newbio232118a0. [DOI] [PubMed] [Google Scholar]
  46. Wagner R. R., Kiley M. P., Snyder R. M., Schnaitman C. A. Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol. 1972 Apr;9(4):672–683. doi: 10.1128/jvi.9.4.672-683.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wagner R. R., Snyder R. M., Yamazaki S. Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol. 1970 May;5(5):548–558. doi: 10.1128/jvi.5.5.548-558.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wallis C., Melnick J. L. Stabilization of enveloped viruses by dimethyl sulfoxide. J Virol. 1968 Sep;2(9):953–954. doi: 10.1128/jvi.2.9.953-954.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zee Y. C., Hackett A. J., Talens L. Vesicular stomatitis virus maturation sites in six different host cells. J Gen Virol. 1970;7(2):95–102. doi: 10.1099/0022-1317-7-2-95. [DOI] [PubMed] [Google Scholar]
  50. Závada J. Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses. J Gen Virol. 1972 Jun;15(3):183–191. doi: 10.1099/0022-1317-15-3-183. [DOI] [PubMed] [Google Scholar]
  51. Závada J., Rosenbergová M. Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol. 1972 Mar;16(2):103–114. [PubMed] [Google Scholar]
  52. Závada J. VSV pseudotype particles with the coat of avian myeloblastosis virus. Nat New Biol. 1972 Nov 22;240(99):122–124. doi: 10.1038/newbio240122a0. [DOI] [PubMed] [Google Scholar]
  53. Závada J., Zázadová Z., Malír A., Koćent A. VSV pseudotype produced in cell line derived from human mammary carcinoma. Nat New Biol. 1972 Nov 22;240(99):124–125. doi: 10.1038/newbio240124a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES